Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
JAK Inhibitors
•
Gastroenterology
•
Dermatology
•
Nephrology
Have you utilized JAK inhibitors in patients on dialysis?
Related Questions
What is your approach to using topical JAK inhibitors in the management of cutaneous manifestations of rheumatic disease?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
How do you approach treatment of SAPHO syndrome?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
How do you counsel and manage joint pain after isotretinoin treatment?
How would you approach the treatment of an SLE patient with refractory mucocutaneous ulcerations and lichenoid skin eruption despite treatment with MMF, Aza, Benlysta, Saphnelo, Rituximab, and JAK inhibitors?
What aspects of a patients clinical presentation would make you consider a diagnostic challenge of anakinra to assess for an underlying auto-inflammatory syndrome in hospitalized patient with fever of unknown origin?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
